Close
Help





JOURNAL

Cancer Informatics

DNA Copy Number Analysis in Gastrointestinal Stromal Tumors Using Gene Expression Microarrays

Submit a Paper


Cancer Informatics 2008:6 59-75

Published on 27 Mar 2008


Further metadata provided in PDF



Sign up for Email Alerts and keep in touch with Cancer Informatics journal news, updates, events and articles

Cristina R. Antonescu1, Kai Wu2, Guoliang Leon Xing3, Manqiu Cao2, Yaron Turpaz4, Margaret A. Leversha5, Earl Hubbell3, Robert G. Maki6, C. Garrett Miyada7, and Raji Pillai8

1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY. 2Intel Corporation, Santa Clara, CA. 3Affymetrix Inc., Santa Clara, CA. 4Lilly Singapore Centre for Drug Discovery, Singapore. 5Molecular Cytogenetics Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY. 6Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. 7NuGEN Inc, San Carlos, CA. 8Pathwork Diagnostics, Sunnyvale, CA.

Abstract

We report a method, Expression-Microarray Copy Number Analysis (ECNA) for the detection of copy number changes using Affymetrix Human Genome U133 Plus 2.0 arrays, starting with as little as 5 ng input genomic DNA. An analytical approach was developed using DNA isolated from cell lines containing various X-chromosome numbers, and validated with DNA from cell lines with defined deletions and amplifications in other chromosomal locations. We applied this method to examine the copy number changes in DNA from 5 frozen gastrointestinal stromal tumors (GIST). We detected known copy number aberrations consistent with previously published results using conventional or BAC-array CGH, as well as novel changes in GIST tumors. These changes were concordant with results from Affymetrix 100K human SNP mapping arrays. Gene expression data for these GIST samples had previously been generated on U133A arrays, allowing us to explore correlations between chromosomal copy number and RNA expression levels. One of the novel aberrations identified in the GIST samples, a previously unreported gain on 1q21.1 containing the PEX11B gene, was confirmed in this study by FISH and was also shown to have significant differences in expression pattern when compared to a control sample. In summary, we have demonstrated the use of gene expression microarrays for the detection of genomic copy number aberrations in tumor samples. This method may be used to study copy number changes in other species for which RNA expression arrays are available, e.g. other mammals, plants, etc., and for which SNPs have not yet been mapped.



Downloads

PDF  (1.49 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Cancer Informatics
The quality of each of the reviews was outstanding, and greatly helped me make the paper so much more readable and valuable.  The entire process was so much more supportive and communicative than with other journals I have dealt with.  Congratulations on building a fantastic academic publishing organization.
Dr Roger Day (University of Pittsburgh Departments of Biomedical Informatics and Biostatistics, University of Pittsburgh Cancer Institute, PA, USA)
More Testimonials

Quick Links


New article and journal news notification services